Understanding Aerius 5 MSD
Aerius 5 MSD is a pharmaceutical-grade desloratadine formulation manufactured by MSD for laboratory investigation of antihistamine mechanisms. Desloratadine is a non-sedating H1 histamine receptor antagonist that demonstrates selective binding affinity for peripheral H1 receptors while exhibiting minimal penetration across the blood-brain barrier in preclinical models. Researchers at Stroid UK Shop utilise this compound to examine allergic cascade modulation, inflammatory mediator release, and histamine receptor pharmacology in controlled experimental settings.
Laboratory Applications
This desloratadine preparation enables comprehensive studies of antihistamine receptor binding kinetics and downstream signalling pathway modulation. Research applications include investigating mast cell degranulation inhibition, cytokine release suppression, and inflammatory response characterisation in cellular models. Scientists examining allergic rhinitis pathophysiology, urticaria mechanisms, and histamine-mediated vascular permeability changes frequently incorporate this compound into their experimental protocols. The pharmaceutical formulation provides standardised dosing consistency essential for reproducible research outcomes across multiple studies. Laboratories studying desloratadine and other drugs benefit from the controlled manufacturing standards ensuring batch-to-batch consistency.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Desloratadine 5mg |
| Manufacturer | MSD |
| CAS Number | 100643-71-8 |
| Molecular Formula | C₁₉H₁₉ClN₂ |
| Molecular Weight | 310.82 g/mol |
| Storage | Room temperature, dry |
Research facilities studying broader categories including SARMs and peptides often incorporate antihistamine compounds like desloratadine to understand receptor selectivity patterns and compare binding affinities across different molecular classes.
Research Compliance
Aerius 5 MSD desloratadine tablets are supplied exclusively for in-vitro laboratory research applications. This pharmaceutical compound is intended solely for qualified researchers conducting studies on antihistamine mechanisms, allergic response pathways, and H1 receptor pharmacology. Not approved for human consumption, therapeutic use, or any application outside controlled laboratory environments.
